Pure Biologics S.A. (WSE:PUR)

Pure Biologics Ratios and Metrics

Market cap in millions PLN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	22	64	42	52	175	184
Market Cap Growth	55.93%	53.27%	-18.86%	-70.44%	-4.91%	226.98%
Enterprise Value	36	77	73	38	140	183
Last Close Price	5.39	10.25	7.53	13.71	46.37	66.45
PS Ratio	-	-	-	78.31	690.40	322.41
PB Ratio	-1.64	-4.91	22.22	2.83	4.44	-63.88
P/TBV Ratio	-	-	25.71	2.88	4.48	-
EV/Sales Ratio	-	-	-	58.12	549.99	319.15
EV/FCF Ratio	-2.61	-	-	-	-	-
Debt / Equity Ratio	-1.07	-1.07	6.84	0.16	0.08	-1.73
Asset Turnover	-	-	-	0.02	0.01	0.03
Quick Ratio	0.13	0.13	2.30	1.75	7.61	0.57
Current Ratio	0.13	0.14	2.70	1.88	7.75	0.72
Return on Equity (ROE)	-	-	-100.50%	-88.62%	-64.29%	-1053.88%
Return on Assets (ROA)	-62.78%	-61.72%	-16.89%	-38.47%	-19.82%	-36.09%
Return on Capital (ROIC)	-123.79%	-98.14%	-26.17%	-48.39%	-29.32%	-114.55%
Earnings Yield	-71.83%	-30.15%	-84.86%	-49.39%	-6.71%	-6.38%
FCF Yield	-63.05%	-16.80%	-55.72%	-44.65%	-14.09%	-1.04%
Buyback Yield / Dilution	-11.96%	-9.27%	-41.50%	-1.48%	-34.29%	-8.48%

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.